You are here Home Resources and guidance Sponsors Alexion Pharmaceuticals Australasia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (14) Prescription medicine registration (7) Australian public assessment report (AusPar) (6) Designation or determination (2) Prescription medicine decision summary (1) Prescription medicine evaluation (1) Date 2026 (2) 2025 (1) 2024 (6) 2023 (2) 2022 (1) 2021 (4) 2020 (2) 2019 (5) 2018 (1) 2017 (1) 2016 (5) 2009 (1) Search Sponsor content31 result(s) found, displaying 31 to 31 SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial (138885) 20 March 2009 ARTG Australian Register of Therapeutic Goods (ARTG) information for SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial. Pages First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4
SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial (138885) 20 March 2009 ARTG Australian Register of Therapeutic Goods (ARTG) information for SOLIRIS eculizumab 300 mg/30 mL concentrated solution for intravenous infusion vial.